November 26, 2025 · Form 4 insider transaction
Tessari Eben sold 200 shares of Kiniksa Pharmaceuticals Ltd. at $42.89 per share, a transaction worth $8.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.